Coronary stent thrombosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Stent thrombosis}} | {{Stent thrombosis}} | ||
{{CMG}} ; '''Associate Editors-In-Chief:''' Smita Kohli, M.D.; [[ William J Gibson]]; [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S. | {{CMG}} ; '''Associate Editors-In-Chief:''' Smita Kohli, M.D.; [[ William J. Gibson]]; [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S. | ||
==[[Stent thrombosis introduction|Introduction]]== | ==[[Stent thrombosis introduction|Introduction]]== |
Revision as of 12:24, 16 July 2011
Coronary stent thrombosis Microchapters |
Epidemiology and Demographics |
---|
Coronary stent thrombosis On the Web |
Risk calculators and risk factors for Coronary stent thrombosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editors-In-Chief: Smita Kohli, M.D.; William J. Gibson; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
Introduction
Definition
Overview | Issues with interpreting data | Definition based on timing of ST | Definition based on certainty of ST
Incidence
Relation to Bare Metal Stents | Relation to Drug Eluting Stents | Sirolimus eluting stent vs Paclitaxel eluting stent | Relation to antiplatelet medications
Mechanism and Pathophysiology
Overview | Mechanisms and pathophysiology | Clinical trial data
Etiology
Predictors of stent thrombosis | Risk factors for early ST | Risk factors for late ST | Risk factors for very late ST
Premature discontinuation of antiplatelet therapy
Incidence | Predictors | Risk associated with premature discontinuation | Risk associated with late discontinuation | Duration of therapy | Failure of therapy | Prevention of premature discontinuation
Treatment
Prognosis
Recurrence of stent thrombosis | Myocardial infarction